GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » Days Payable

LFCR (Lifecore Biomedical) Days Payable : 40.33 (As of Feb. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical Days Payable?

Lifecore Biomedical's average Accounts Payable for the three months ended in Feb. 2025 was $11.2 Mil. Lifecore Biomedical's Cost of Goods Sold for the three months ended in Feb. 2025 was $25.3 Mil. Hence, Lifecore Biomedical's Days Payable for the three months ended in Feb. 2025 was 40.33.

The historical rank and industry rank for Lifecore Biomedical's Days Payable or its related term are showing as below:

LFCR' s Days Payable Range Over the Past 10 Years
Min: 24.23   Med: 53.94   Max: 200.2
Current: 71.97

During the past 13 years, Lifecore Biomedical's highest Days Payable was 200.20. The lowest was 24.23. And the median was 53.94.

LFCR's Days Payable is ranked worse than
58.11% of 943 companies
in the Drug Manufacturers industry
Industry Median: 85.92 vs LFCR: 71.97

Lifecore Biomedical's Days Payable declined from Feb. 2024 (66.51) to Feb. 2025 (40.33). It may suggest that Lifecore Biomedical accelerated paying its suppliers.


Lifecore Biomedical Days Payable Historical Data

The historical data trend for Lifecore Biomedical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical Days Payable Chart

Lifecore Biomedical Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159.73 200.20 73.93 84.96 81.17

Lifecore Biomedical Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.51 70.87 81.11 70.05 40.33

Competitive Comparison of Lifecore Biomedical's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecore Biomedical's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Days Payable distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Days Payable falls into.


;
;

Lifecore Biomedical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Lifecore Biomedical's Days Payable for the fiscal year that ended in May. 2024 is calculated as

Days Payable (A: May. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: May. 2023 ) + Accounts Payable (A: May. 2024 )) / count ) / Cost of Goods Sold (A: May. 2024 )*Days in Period
=( (22.097 + 16.334) / 2 ) / 86.411*365
=19.2155 / 86.411*365
=81.17

Lifecore Biomedical's Days Payable for the quarter that ended in Feb. 2025 is calculated as:

Days Payable (Q: Feb. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Nov. 2024 ) + Accounts Payable (Q: Feb. 2025 )) / count ) / Cost of Goods Sold (Q: Feb. 2025 )*Days in Period
=( (14.967 + 7.405) / 2 ) / 25.309*365 / 4
=11.186 / 25.309*365 / 4
=40.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifecore Biomedical Days Payable Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecore Biomedical Business Description

Traded in Other Exchanges
Address
3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Executives
Wynnefield Partners Small Cap Value Lp I 10 percent owner 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Christopher S Kiper director 12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Raymond T. White director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway director C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Raymond H Diradoorian director C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter director C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg officer: Chief Financial Officer C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall officer: Executive Vice President 3515 LYMAN BLVD., CHASKA MN 55318